Check it out: http://www.cnbc.com/id/15840232?video=647792797

Chicago is my kinda town. Meet me there April 27-30 for the World Congress on Industrial Biotechnology and Bioprocessing. There’s a great lineup of sessions and speakers highlighting the latest in industrial biotechnology.  Now in its fifth year, the Congress continues to grow in size and scope. …

BIO will debut a new conference in Boston April 22-23.  The National Venture Conference will draw early-stage, private biotech companies and healthcare venture partners.  I hope to see you there, but in the meantime, check out http://bnvc.bio.org for more details in the coming months.

The 2008 BIO International Convention is the place to be for anyone covering the life sciences, investments and policy.  If you have attended in the past, you'll notice a few changes - the day pattern will be Tuesday through Friday, come into town early though for the golf outing. I'll be dragging…

Without a supportive legislative and regulatory environment, biotech companies cannot raise the funds necessary to get a product to market.  The panelists explored the pressing policy issues which could have a significant impact on the industry, from the creation of a pathway for the approval of…

The debate surrounding cancer endpoints has focused on the issue of quality of life and progression. Panelists shared some of the challenges in assessing quality of life, since it can be a fickle and subjective process. The data can be hard to nail down since patients don't always fill out the…

Panelists in the diabetes panel stressed the importance of the growing prevalence of the disease – it’s expected to more than double by 2030. Those are big numbers, particularly because diabetes is the number one cause of preventable blindness. There is a light on the horizon - several new…

The CEO & Investor Conference started out strong with several therapeutic workshops. The Pain “A Pain Free“ Guide to Current Therapies panel shared efforts to develop drugs with greater efficiency and fewer side-effects, including a patch for the site of pain (NeurogesX, Inc.), the use of…

There's a reason why they call it 'the largest investor conference focused on the biotech industry.' The next few days will bring out the major players in biotech, from investors to venture capitalists to companies with innovations worthy of writing home about. And the Daily Update is your cheat…

Two days until the CEO & Investor Conference! I'll be there, will you?